64 related articles for article (PubMed ID: 7680400)
21. Aberrant cytoplasmic expression of MHCII confers worse progression free survival in diffuse large B-cell lymphoma.
Kendrick S; Rimsza LM; Scott DW; Slack GW; Farinha P; Tan KL; Persky D; Puvvada S; Connors JM; Sehn L; Gascoyne RD; Schmelz M
Virchows Arch; 2017 Jan; 470(1):113-117. PubMed ID: 27888357
[No Abstract] [Full Text] [Related]
22. FOXP1 suppresses immune response signatures and MHC class II expression in activated B-cell-like diffuse large B-cell lymphomas.
Brown PJ; Wong KK; Felce SL; Lyne L; Spearman H; Soilleux EJ; Pedersen LM; Møller MB; Green TM; Gascoyne DM; Banham AH
Leukemia; 2016 Mar; 30(3):605-16. PubMed ID: 26500140
[TBL] [Abstract][Full Text] [Related]
23. Lectin-like transcript 1 is a marker of germinal center-derived B-cell non-Hodgkin's lymphomas dampening natural killer cell functions.
Germain C; Guillaudeux T; Galsgaard ED; Hervouet C; Tekaya N; Gallouet AS; Fassy J; Bihl F; Poupon G; Lazzari A; Spee P; Anjuère F; Pangault C; Tarte K; Tas P; Xerri L; Braud VM
Oncoimmunology; 2015 Aug; 4(8):e1026503. PubMed ID: 26405582
[TBL] [Abstract][Full Text] [Related]
24. Molecular classification, pathway addiction, and therapeutic targeting in diffuse large B cell lymphoma.
Puvvada S; Kendrick S; Rimsza L
Cancer Genet; 2013; 206(7-8):257-65. PubMed ID: 24080457
[TBL] [Abstract][Full Text] [Related]
25. Histone deacetylase inhibitors activate CIITA and MHC class II antigen expression in diffuse large B-cell lymphoma.
Cycon KA; Mulvaney K; Rimsza LM; Persky D; Murphy SP
Immunology; 2013 Oct; 140(2):259-72. PubMed ID: 23789844
[TBL] [Abstract][Full Text] [Related]
26. Influence of Tumor Location on the Composition of Immune Infiltrate and Its Impact on Patient Survival. Lessons from DCBCL and Animal Models.
Galand C; Donnou S; Molina TJ; Fridman WH; Fisson S; Sautès-Fridman C
Front Immunol; 2012; 3():98. PubMed ID: 22566974
[TBL] [Abstract][Full Text] [Related]
27. Partial plasma cell differentiation as a mechanism of lost major histocompatibility complex class II expression in diffuse large B-cell lymphoma.
Wilkinson ST; Vanpatten KA; Fernandez DR; Brunhoeber P; Garsha KE; Glinsmann-Gibson BJ; Grogan TM; Teruya-Feldstein J; Rimsza LM
Blood; 2012 Feb; 119(6):1459-67. PubMed ID: 22167754
[TBL] [Abstract][Full Text] [Related]
28. A strategy for full interrogation of prognostic gene expression patterns: exploring the biology of diffuse large B cell lymphoma.
Rimsza LM; Unger JM; Tome ME; Leblanc ML
PLoS One; 2011; 6(8):e22267. PubMed ID: 21829609
[TBL] [Abstract][Full Text] [Related]
29. Coordinate loss of MHC class II expression in the diffuse large B cell lymphoma cell line OCI-Ly2 is due to a novel mutation in RFX-AP.
Bushway M; Cycon KA; Mulvaney K; Murphy SP
Immunogenetics; 2010 Feb; 62(2):109-16. PubMed ID: 20024540
[TBL] [Abstract][Full Text] [Related]
30. The immunogenicity of L1210 lymphoma clones correlates with their ability to function as antigen-presenting cells.
Cycon KA; Clements JL; Holtz R; Fuji H; Murphy SP
Immunology; 2009 Sep; 128(1 Suppl):e641-51. PubMed ID: 19740325
[TBL] [Abstract][Full Text] [Related]
31. Gene expression predicts overall survival in paraffin-embedded tissues of diffuse large B-cell lymphoma treated with R-CHOP.
Rimsza LM; Leblanc ML; Unger JM; Miller TP; Grogan TM; Persky DO; Martel RR; Sabalos CM; Seligmann B; Braziel RM; Campo E; Rosenwald A; Connors JM; Sehn LH; Johnson N; Gascoyne RD
Blood; 2008 Oct; 112(8):3425-33. PubMed ID: 18544678
[TBL] [Abstract][Full Text] [Related]
32. Loss of major histocompatibility class II expression in non-immune-privileged site diffuse large B-cell lymphoma is highly coordinated and not due to chromosomal deletions.
Rimsza LM; Roberts RA; Campo E; Grogan TM; Bea S; Salaverria I; Zettl A; Rosenwald A; Ott G; Muller-Hermelink HK; Delabie J; Fisher RI; Unger JM; Leblanc M; Staudt LM; Jaffe ES; Gascoyne RD; Chan WC; Weisenburger DD; Greiner T; Braziel RM; Miller TP
Blood; 2006 Feb; 107(3):1101-7. PubMed ID: 16239429
[TBL] [Abstract][Full Text] [Related]
33. The biology of human lymphoid malignancies revealed by gene expression profiling.
Staudt LM; Dave S
Adv Immunol; 2005; 87():163-208. PubMed ID: 16102574
[TBL] [Abstract][Full Text] [Related]
34. Loss of B7.2 (CD86) and intracellular adhesion molecule 1 (CD54) expression is associated with decreased tumor-infiltrating T lymphocytes in diffuse B-cell large-cell lymphoma.
Stopeck AT; Gessner A; Miller TP; Hersh EM; Johnson CS; Cui H; Frutiger Y; Grogan TM
Clin Cancer Res; 2000 Oct; 6(10):3904-9. PubMed ID: 11051236
[TBL] [Abstract][Full Text] [Related]
35. HLA class I expression on human ovarian carcinoma cells correlates with T-cell infiltration in vivo and T-cell expansion in vitro in low concentrations of recombinant interleukin-2.
Kooi S; Zhang HZ; Patenia R; Edwards CL; Platsoucas CD; Freedman RS
Cell Immunol; 1996 Dec; 174(2):116-28. PubMed ID: 8954611
[TBL] [Abstract][Full Text] [Related]
36. High numbers of tumour-infiltrating activated cytotoxic T lymphocytes, and frequent loss of HLA class I and II expression, are features of aggressive B cell lymphomas of the brain and testis.
Riemersma SA; Oudejans JJ; Vonk MJ; Dreef EJ; Prins FA; Jansen PM; Vermeer MH; Blok P; Kibbelaar RE; Muris JJ; Schuuring EM; Kluin PM
J Pathol; 2005 Jul; 206(3):328-36. PubMed ID: 15887291
[TBL] [Abstract][Full Text] [Related]
37. MHC class II-restricted tumor antigens recognized by CD4+ T cells: new strategies for cancer vaccine design.
Zeng G
J Immunother; 2001; 24(3):195-204. PubMed ID: 11394496
[TBL] [Abstract][Full Text] [Related]
38. The role of CD4+ tumor-infiltrating lymphocytes in human solid tumors.
Goedegebuure PS; Eberlein TJ
Immunol Res; 1995; 14(2):119-31. PubMed ID: 8530876
[TBL] [Abstract][Full Text] [Related]
39. Deficient tumor-infiltrating T-lymphocyte response in malignant lymphoma: relationship to HLA expression and host immunocompetence.
List AF; Spier CM; Miller TP; Grogan TM
Leukemia; 1993 Mar; 7(3):398-403. PubMed ID: 7680400
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
